SynCardia shareholder purchase makes MicroMed Cardiovascular private
E-Wilson LLC has accumulated 97.5 percent of the outstanding shares for MicroMed Cardiovascular. E-Wilson was formed by Rodger Ford, shareholder and CEO of SynCardia Systems and David Mackstaller, SynCardia shareholder and its vice president of development.
The Houston-based E-Wilson said it is now the single shareholder of MicroMed, which manufactures a small implantable electric pump, DeBakey VAD (Ventricular Assist Device), intended to increase the cardiac output of a patient with a failing left ventricle.
The DeBakey VAD is now approved in Europe with a CE Mark and in the U.S. as a pediatric VAD under a Humanitarian Device Exemption. A bridge-to-transplant clinical study is underway in the U.S. under an IDE.
According to the company, the process of this acquisition began in February with a $10 million credit agreement, and since that point E-Wilson has continued to purchase its shares held by Absolute Capital Management Holdings.
The Houston-based E-Wilson said it is now the single shareholder of MicroMed, which manufactures a small implantable electric pump, DeBakey VAD (Ventricular Assist Device), intended to increase the cardiac output of a patient with a failing left ventricle.
The DeBakey VAD is now approved in Europe with a CE Mark and in the U.S. as a pediatric VAD under a Humanitarian Device Exemption. A bridge-to-transplant clinical study is underway in the U.S. under an IDE.
According to the company, the process of this acquisition began in February with a $10 million credit agreement, and since that point E-Wilson has continued to purchase its shares held by Absolute Capital Management Holdings.